NP Screen has developed a diagnostic screening test for Nasopharyngeal Cancer. This genetic test allows people to determine whether or not they have the disease at a very early stage. Thereby improving their chances for a successful recovery. Our mission is to establish NP Screen as the precision standard for the early detection of nasopharyngeal cancer, and improve the quality of life and survival rates for individuals at risk for NPC worldwide. Continue to develop innovative screening technologies and conduct clinical studies in order to develop even more sensitive and quantifiable standards for the diagnosis of disease.